Search Orphan Drug Designations and Approvals
-
Generic Name: | tamibarotene |
---|---|
Date Designated: | 08/16/2017 |
Orphan Designation: | Treatment of acute myeloid leukemia (AML) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Syros Pharmaceuticals, Inc. 620 Memorial Drive Suite 300 Cambridge, Massachusetts 02139 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-